When is crossover desirable in cancer drug trials and when is it problematic?

A. Haslam, V. Prasad

Research output: Contribution to journalEditorialpeer-review

27 Scopus citations
Original languageEnglish (US)
Pages (from-to)1080
Number of pages1
JournalAnnals of Oncology
Issue number5
StatePublished - May 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this